We continue to invest heavily in quality, regulatory compliance, and modernisation

Rishad Dadachanji, MD, Kaisha Packaging shares insights on emerging industry trends, new technologies showcased at CPhI & P-MEC, and how the Dadachanji Group is strengthening its integrated ecosystem to serve both domestic and global pharma markets

- 

What key industry trends are visible at CPhI & P-MEC this year, and how is your company positioning itself in response?

At CPhI & P-MEC India 2025, we see the pharma landscape evolving rapidly toward integration, innovation, and sustainability. Companies are moving from standalone operations to end-to-end partnerships, seeking collaborators who can deliver quality, compliance, and reliability across the product lifecycle — all while embracing digitisation, automation, and environmental responsibility.

The Dadachanji Group is fully aligned with this shift. Through our integrated ecosystem — spanning engineering solutions to machine building, automation & cleanroom equipment (Kairish Innotech), primary and secondary packaging (Kaisha Packaging), sterile contract manufacturing (Sovereign Pharma), and injectable product development (Kaisha Lifesciences) — we offer seamless, turnkey solutions that meet global standards.

We continue to invest heavily in quality, regulatory compliance, and modernisation, including EU GMP (Annexure 1)-ready isolator upgrades at Sovereign Pharma. Across all businesses, we're embedding automation, sustainability, and digital traceability into our operations, while expanding our export footprint — with Kaisha Packaging now serving over 24 countries worldwide.

Which new products, technologies, or solutions are you showcasing at this year's event?